Drugs that contain Sonidegib Phosphate

1. List of Odomzo drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8178563 SUN PHARM Compounds and compositions as hedgehog pathway modulators
Jul, 2029

(6 years from now)

US8063043 SUN PHARM Salts of N-[6-cis-2,6-dimethylmorpholin-4-yl)pyridine-3-yl]-2-methyl-4′-(trifluoromethoxy)[1,1′-biphenyl]-3-carboxamide
Sep, 2029

(6 years from now)

US10266523 SUN PHARM Crystaline forms of N-[6-(cis-2,6-dimethylmorpholine-4-yl)pyridine-3-yl]-2-Methyl-4′-(trifluoromethoxy) [1,1′-biphenyl]-3-Methanamide monophosphate, and process of preparation thereof
Mar, 2036

(12 years from now)

Do you want to check out ODOMZO patents from before 2022?

Market Authorisation Date: 24 July, 2015

Treatment: Treatment of basal cell carcinoma

Dosage: CAPSULE;ORAL

More Information on Dosage

ODOMZO family patents

14

United States

6

China

4

Japan

4

Argentina

4

European Union

3

Korea, Republic of

3

Spain

3

Portugal

3

Poland

3

Norway

3

Brazil

2

Ecuador

2

Australia

EA

2

EA

2

El Salvador

2

Israel

2

Canada

2

New Zealand

2

Denmark

2

Honduras

2

Tunisia

2

Peru

2

Malaysia

2

Costa Rica

2

Chile

2

Cyprus

2

Jordan

2

Ukraine

2

Morocco

2

Hong Kong

2

San Marino

2

Mexico

2

Georgia

2

Cuba

2

South Africa

2

Slovenia

2

Taiwan

1

Colombia

1

Luxembourg

1

Croatia

1

Dominican Republic

1

Netherlands

1

Nicaragua

1

ME

1

Singapore

1

Russia

1

Guatemala

1

Hungary

1

Lithuania

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic